John Botson, MD, provides his perspective on including immunodulatory therapy in combination with pegloticase and encourages clinicians to evolve their standard of care in the treatment of uncontrolled gout.
John K. Botson, MD, RPh, CCD
John K Botson MD, RPh, CCD and President of the Alaska Rheumatology Alliance and a Rheumatologist with Orthopedic Physicians Alaska.
